The cardiac glycosides market in Denmark is showing a gradual downward trend from 2024 to 2028. In 2023, the market stood at approximately 11.68 million Danish Krones. Forecasted sales show a decrease from 11.18 million in 2024 to 9.23 million in 2028. The year-on-year variation indicates a decline of about 4.5% from 2024 to 2025, 4.6% from 2025 to 2026, 4.8% from 2026 to 2027, and 4.8% from 2027 to 2028. The compound annual growth rate (CAGR) over the next five years is approximately -4.4%, reflecting a consistent contraction in the market.
Future trends to watch for include advancements in alternative treatments for heart conditions, shifts in healthcare policies, and technological innovations. Monitoring these factors is crucial to understanding the dynamics of the cardiac glycosides market in Denmark.
